| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 270,209 | 287,501 | 319,570 | 363,903 | | Cost of Revenue | 200,608 | 212,052 | 222,740 | 308,998 | | | Gross Profit | 69,601 | 75,449 | 96,830 | 54,905 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 73,330 | 79,217 | 74,859 | 113,036 | | Non Recurring |
-
| (9,307) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,158 | 5,539 | 21,971 | (58,131) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 910 | 5,539 | 21,971 | (58,131) | | Interest Expense | (258) | (21) | 279 | 662 | | Income Before Tax | 1,168 | 5,560 | 21,692 | (58,793) | | Income Tax Expense | (2,031) | 4,036 | 5,606 | (2,615) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,199 | 1,524 | 16,086 | (56,178) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,199 | 1,524 | 16,086 | (56,178) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,199 | $1,524 | $16,086 | ($56,178) |
|
0.03% Nasdaq 0.00%
Income Statement
